MAKO Surgical
MAKO Surgical develops the Mako SmartRobotics platform, a robotic-arm assisted orthopedic surgery system featuring haptic feedback for precision-guided knee and hip replacements, sold to hospitals via Stryker's enterprise sales force.
- Company typePrivate
- Founded2004
- HeadquartersFort Lauderdale, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What MAKO Surgical does
MAKO Surgical is a medical device company specializing in robotic-arm assisted surgery for orthopedic procedures, founded in 2004 and headquartered in Fort Lauderdale, Florida. The company developed the Mako SmartRobotics platform, which integrates advanced imaging with robotic assistance to enable personalized surgical planning and precision-guided bone preparation. Its core technical differentiator is haptic feedback technology, most recently embodied in the Mako Total Knee 2.0 launched in March 2023, which provides surgeons real-time tactile guidance during bone cutting and implant placement in knee replacement procedures. Each system costs approximately $1 million and is sold to hospitals and medical centers performing orthopedic surgeries.
MAKO's business model relies on enterprise field sales to acute-care hospitals and orthopedic surgery centers, with multi-year service contracts and bundled clinical training and demonstration support. Marketing is conducted through medical conferences, hospital showcases, and direct engagement with hospital leadership. The company was publicly traded on NASDAQ (ticker: MAKO) before being acquired by Stryker Corporation in 2013 for $1.65 billion, after which it became a wholly-owned subsidiary with its technology integrated into Stryker's broader musculoskeletal portfolio and distributed globally through Stryker's direct sales force. Prior to acquisition, MAKO raised approximately $164M across multiple venture rounds between 2005 and 2012 from investors including Sycamore Ventures, Tudor Investments, Alta Partners, and Deerfield, and acquired Pipeline Biomedical Holdings in October 2013.
MAKO Surgical firmographics
Firmographics- Name
- MAKO Surgical
- Legal name
- MAKO Surgical Corp.
- Website
- https://makosurgical.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- MAKO Surgical develops the Mako SmartRobotics platform, a robotic-arm assisted orthopedic surgery system featuring haptic feedback for precision-guided knee and hip replacements, sold to hospitals via Stryker's enterprise sales force.
- Ownership category
- akta.pro rank
MAKO Surgical industry classification
Industry- Product category
- Orthopedic Surgical Robotics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG), Hip & Knee Reconstruction (Arthroplasty) (HLAKALAH), Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Healthcare & Assistive Robotics (HDAAAIAC)
Keywords
Where MAKO Surgical is headquartered
LocationHeadquarters
- HQ city
- Fort Lauderdale
- HQ country
- United States
- HQ region
- North America
Markets served
MAKO Surgical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Medical robot system for orthopedic surgical procedures |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
MAKO Surgical product offering
Product offeringCore offering
MAKO Surgical designs, manufactures, and sells robotic-arm assisted surgical systems for orthopedic procedures, primarily total knee and hip replacements. Its Mako SmartRobotics platform integrates CT-based 3D surgical planning with haptic feedback-guided robotic arms that constrain the surgeon's movements to a predefined volume, enabling precise bone cutting and implant placement. The systems are sold to hospitals and medical centers, with clinical demonstration, training, and service support bundled into enterprise sales contracts.
Product overview
MAKO Surgical (acquired by Stryker Corporation for $1.65B) offers the Mako SmartRobotics platform, an orthopedic surgical robotics system. The core product line includes the Mako SmartRobotics system and its specialized application Mako Total Knee 2.0, which features haptic feedback technology for precision-guided knee replacement surgeries. The platform enables personalized orthopedic surgeries with robotic assistance.
Differentiator
Problem solved
Functional benefit
Products and services
- Mako SmartRobotics Robotic-arm assisted orthopedic surgical system for total and partial knee and hip replacement procedures. Combines CT-based 3D preoperative surgical planning with a haptic-feedback robotic arm that guides the surgeon during bone preparation and implant placement. Sold to hospitals and medical centers as a capital equipment purchase with bundled clinical demonstration, training, and service support.
- Mako Total Knee 2.0 Updated application/software release for the Mako SmartRobotics platform targeting total knee replacement. Features haptic feedback technology that provides surgeons with real-time tactile guidance during bone cutting, helping prevent over-cutting and improving implant positioning accuracy. Aimed at hospitals and orthopedic surgery centers performing total knee arthroplasty.
Companies that use MAKO Surgical
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
MAKO Surgical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
MAKO Surgical partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights4 records
MAKO Surgical competitors and assessment
Company assessmentEmerging players
- Brainlab: Brainlab provides surgical navigation, planning, and increasingly robotics-adjacent software; it competes indirectly via OR integration and digital surgery workflows relevant to Mako's surgical planning stack.
- Renishaw (Neuromate / neurosurgical robotics): Renishaw's neuromate and neurosurgical robotics capabilities overlap with Mako's haptic-feedback and navigation expertise, representing an adjacent robotic-surgery platform with comparable precision engineering roots.
- Globus Medical (ExcelsiusGPS): Globus Medical's ExcelsiusGPS extends surgical robotics into spine and increasingly orthopedic applications, competing with Mako for hospital capital and OR integration real estate.
Direct peers
- Think Surgical (TSolution One): Think Surgical develops the TSolution One active robotic system for orthopedic joint replacement, directly competing with Mako in bone preparation and implant placement for knee and hip procedures.
- Zimmer Biomet (ROSA): Zimmer Biomet's ROSA Knee and ROSA Hip robotic platforms compete head-to-head with Mako in orthopedic surgical robotics, leveraging Zimmer's deep hospital and orthopedic surgeon relationships.
- Johnson & Johnson DePuy Synthes (Velys): J&J's Velys robotic-assisted solution targets the same total knee arthroplasty use case as Mako, with comparable hospital procurement channels and digital surgical planning workflows.
- Smith+Nephew (CORI): Smith+Nephew's CORI handheld and CORI Surgical System is a direct competitor in robotic-assisted orthopedic surgery, targeting the same hospital and ASC customers for knee arthroplasty.
- Stryker (Mako platform): Stryker is both the parent and primary operator of the Mako platform; comparable because Mako competes in the same orthopedic surgical robotics category as direct alternatives while operating inside Stryker's broader implant and instrumentation portfolio.
Broad incumbents
- Medtronic (Mazor / Hugo): Medtronic's Mazor spine robotics and Hugo surgical platform represent broader medtech incumbents expanding into surgical robotics, with overlapping hospital buyers and digital surgery strategies even though they are less specialized in knee arthroplasty.
- Intuitive Surgical (da Vinci): Intuitive's da Vinci platform dominates soft-tissue robotic surgery and competes for the same hospital capital budgets, OR integration footprints, and surgeon training resources as Mako, though in a different surgical specialty.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights4 records
Customer concentration
MAKO Surgical social profiles
Digital presenceMAKO Surgical financial estimates
Financial estimateRevenue estimate
Valuation estimate
MAKO Surgical leadership team
Management profileNumber of profiles
Profiles2 records
MAKO Surgical funding detail
Funding detailFunding overview
Funding rounds6 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MAKO Surgical M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MAKO Surgical
What does MAKO Surgical do?
MAKO Surgical designs, manufactures, and sells robotic-arm assisted surgical systems for orthopedic procedures, primarily total knee and hip replacements. Its Mako SmartRobotics platform integrates CT-based 3D surgical planning with haptic feedback-guided robotic arms that constrain the surgeon's movements to a predefined volume, enabling precise bone cutting and implant placement. The systems are sold to hospitals and medical centers, with clinical demonstration, training, and service support bundled into enterprise sales contracts.
Is MAKO Surgical a public or private company?
MAKO Surgical is a private company. It is classified as corporate owned and is currently acquired.
When was MAKO Surgical founded?
MAKO Surgical was founded in 2004. It employs 251 to 500 people.
Where is MAKO Surgical based?
MAKO Surgical is headquartered in Fort Lauderdale, United States, in the North America region.
Who are MAKO Surgical's main competitors?
Emerging players on record are Brainlab, Renishaw (Neuromate / neurosurgical robotics) and Globus Medical (ExcelsiusGPS). Direct peers are Think Surgical (TSolution One), Zimmer Biomet (ROSA), Johnson & Johnson DePuy Synthes (Velys), Smith+Nephew (CORI) and Stryker (Mako platform). Broad incumbents are Medtronic (Mazor / Hugo) and Intuitive Surgical (da Vinci).
Does MAKO Surgical have an API?
No public API is recorded for MAKO Surgical.
What industry is MAKO Surgical in?
MAKO Surgical's product category is Orthopedic Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT). Its NAICS code is 339112 and its SIC code is 3841.